Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (1308)	2/5/2000 12:15:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 2001

David, People tend to think of medical supply/device companies as boring I suppose. V1 suggested that Gliatech should sell off the whole ADCON business at a massive discount. I happen to like these boring ones as long as they meet two criteria. There has to be enough cash coming from the boring side to support the valuation and the cash has to be sufficient to support research on a wild card that's preferably not included in present valuations. GLIA meets those criteria and so does NABI. Moreover, Gliatech is potentially sitting on such a monster cash cow in the ADCONs that the wild card may end up being just frosting - very thick and creamy - on top of the cake. NABI is different, their cash source doesn't show all that much growth, but it happens to provide them with an excellent source of material to scan for new strains of virii. I've already piled in on GLIA. I'm too poor to have a truck; I had to use the Benz which can't hold that much, but still.... Thanks, Torben